×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Protara Therapeutics Announces Third Quarter 2023 Financial Results and Business Update
KLAS 8 News Now
Dosing is progressing well in ADVANCED-1EXP trial evaluating TARA-002 in NMIBC patients with CIS; preliminary results expected in 1H24
1 day ago
Protara Therapeutics (NASDAQ:TARA) Receives Buy Rating from HC Wainwright
Defense World
Protara Therapeutics (NASDAQ:TARA – Get Free Report)'s stock had its “buy” rating reaffirmed by HC Wainwright in a research note issued to...
2 days ago
Opaleye Management sells shares in Protara Therapeutics for $567k
Investing.com South Africa
Opaleye Management Inc., a significant shareholder in Protara Therapeutics, Inc. ( NASDAQ :TARA), has recently sold a portion of its...
18 hours ago
Protara Therapeutics: Q1 Earnings Snapshot
Houston Chronicle
NEW YORK (AP) — NEW YORK (AP) — Protara Therapeutics, Inc. (TARA) on Thursday reported a loss of $11.1 million in its first quarter.
1 week ago
Here's Why We're Watching Protara Therapeutics' (NASDAQ:TARA) Cash Burn Situation
Simply Wall Street
When Might Protara Therapeutics Run Out Of Money? A company's cash runway is the amount of time it would take to burn through its cash reserves...
4 months ago
Protara Therapeutics CMO Resigns, Interim Successor Named - TipRanks.com
Tipranks
Protara Therapeutics (TARA) just unveiled an announcement. Protara Therapeutics, Inc. has announced the resignation of their Chief Medical...
1 month ago
Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity
Yahoo Finance
Friday, Protara Therapeutics Inc (NASDAQ:TARA) shared data from three-month evaluable carcinoma in situ (CIS) patients treated across...
1 month ago
Protara begins dosing in Phase II lymphatic malformation cell therapy trial
Clinical Trials Arena
Protara's Rare Paediatric Disease-designated drug is based on the immunopotentiator Picibanil, a therapy already approved in Japan.
6 months ago
3 Stocks That Could Help You Retire on a Private Island
InvestorPlace
Dreamers can roll the dice on these stocks. Rigetti Computing (RGTI): Rigetti Computing could thrive on the push for quantum technologies.
1 month ago
Protara Therapeutics Launches $45M Private Placement Drive - TipRanks.com
Tipranks
Protara Therapeutics (TARA) has provided an announcement. Protara Therapeutics, Inc. has initiated a private placement, selling over 9...
1 month ago